De-Billemont SRL
Ouverture de faillite 1.2 FTEDe-Billemont reported total assets of €2.89m at the end of the 2022 financial year (annual accounts filed with the NBB on 26 Jul 2023), with 1.2 full-time equivalent.
The score of De-Billemont shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2022
Change 2019 → 2022: Equity -53 % Total assets +345 % Headcount (avg FTE) +9 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
De-Billemont's annual accounts
Filed annual accounts
- Year ended 31 Dec 2022filed on 26 Jul 2023
- Year ended 31 Dec 2021filed on 01 Jul 2022
- Year ended 31 Dec 2020filed on 01 Jun 2021
- Year ended 31 Dec 2019filed on 25 Aug 2020
- Year ended 31 Dec 2018filed on 04 Jun 2019
De-Billemont's financial analysis
- Solvency5.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of De-Billemont
De-Billemont's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0458.756.451
- VAT number
- BE0458756451
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 09 Sep 1996
- Registered office
- 2440 Geel
- Size
- Micro · 1.2 FTE
- Latest accounts
- 2022 · filed on 26 Jul 2023
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
De-Billemont (SRL) has been based in Geel since 1996, active in: retail sale of pharmaceutical products. For 2022, it reports a net profit of 3,052 € and equity of 144,996 €; its revenue is not published. With 1.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 5.0%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to De-Billemont
Companies in the same business, of comparable size and area, outside its group.
- Elbaro Retail sale of pharmaceutical products Merelbeke-Melle · balance sheet €2.78m
- Apotheek Gombert Retail sale of pharmaceutical products Bredene · balance sheet €2.89m
- Pharmacie Henry Retail sale of pharmaceutical products Pont-à-Celles · balance sheet €2.88m
- Jansen - Ceuppens Retail sale of pharmaceutical products Wezembeek-Oppem · balance sheet €2.91m
- Apollonia Apotheek Retail sale of pharmaceutical products Brakel · balance sheet €2.88m
- Linapo Retail sale of pharmaceutical products Lubbeek · balance sheet €2.96m
- Pharmayou Tongeren Retail sale of pharmaceutical products Tongeren-Borgloon · balance sheet €2.99m
- Pharmalaw Retail sale of pharmaceutical products Anderlecht · balance sheet €2.78m
Frequently asked questions about De-Billemont
What is the revenue of De-Billemont?
De-Billemont files its accounts in a format where revenue is optional: it is not published for 2022.
What is the VAT number of De-Billemont?
In Belgium, the VAT number is the company number prefixed with BE: BE0458756451 for De-Billemont, if the company is VAT-registered. Its company number (CBE) is 0458.756.451.
Where is the registered office of De-Billemont?
According to the CBE register, the registered office of De-Billemont is in 2440 Geel.
What is the equity of De-Billemont?
At the close of the 2022 financial year, the equity of De-Billemont amounts to 144,996 €, a solvency of 5.0% of total assets.
How many people work at De-Billemont?
1.2 full-time equivalents on average according to the 2022 social balance sheet.
Who manages De-Billemont?
The register lists 4 active mandates at De-Billemont. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of De-Billemont
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →